Weekly briefing
Market Insights, 26 October 2026
Key developments, a cross-asset dashboard and the events calendar for 26 to 30 October, from the TFOS trading desk.
Weekly briefing
Market Insights, 19 October 2026
Key developments, a cross-asset dashboard and the events calendar for 20 to 23 October, from the TFOS trading desk.
IPO coverage
IPO Review: three September listings, one above its offer price
Electra Therapeutics and Orion180 trade below their IPO prices, ADARx Pharmaceuticals holds above its own: price action and catalysts.
Report
Tokenization: a review for South African investors
What tokenized assets are, how they are regulated, and what they mean for adviser and HNW portfolios. 44 pages.
IPO coverage
The market has its say: how July's IPOs are performing
Post-IPO coverage of Csquare, Standard Nuclear and Scribe Therapeutics: three July listings, three very different receptions.
IPO coverage
Friday IPO Review: six listings, one nearly doubled
APMD up ~98% from its IPO price, Lyntris below its offer: the businesses, catalysts and risks behind six recent listings.
Marketing communication, not independent investment research and not financial advice. Past performance is not a guide to future results. Turlov Family Office Securities (Pty) Ltd is an authorised FSP (52874).